These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Selective inhibition of nicotinamide adenine dinucleotide dependent oxidations by piperazinothioureas. Chaturvedi AK; Parmar SS Biochem Pharmacol; 1973 Sep; 22(18):2355-6. PubMed ID: 4354787 [No Abstract] [Full Text] [Related]
3. Substituted benzoxazole-benzthiazole-2-thiones: interrelationship between anticonvulsant activity and inhibition of nicotinamide adenine dinucleotide-dependent oxidations and monoamine oxidase. Misra RS; Barthwal JP; Parmar SS; Brumleve SJ J Pharm Sci; 1974 Mar; 63(3):401-4. PubMed ID: 4362352 [No Abstract] [Full Text] [Related]
4. Anticonvulsant activity and selective inhibition of nicotinamide adenine dinucleotide-dependent oxidations by 1,3,5-trisubstituted pyrazolines. Singh SP; Chaudhari A; Barthwal JP; Parmar SS J Pharm Sci; 1974 Dec; 63(12):1948-50. PubMed ID: 4375177 [No Abstract] [Full Text] [Related]
5. Synthesis of substituted piperidino carbamides: correlation between CNS effects and selective inhibition of NAD-dependent oxidations. Gupta AK; Dwivedi C; Gupta TK; Parmar SS; Cornatzer WE J Pharm Sci; 1974 Aug; 63(8):1227-30. PubMed ID: 4369258 [No Abstract] [Full Text] [Related]
6. Role of ring substitution on the inhibition of nicotinamide adenine dinucleotide dependent oxidations by 2-methyl-3-ortho-tolyl-6-hydroxy-4-quinazolone. Parmar SS; Nagar S Jpn J Pharmacol; 1969 Sep; 19(3):460-2. PubMed ID: 4310472 [No Abstract] [Full Text] [Related]
7. Selective inhibition of nicotinamide adenine dinucleotide dependent oxidation by 2-methyl-3-o-tolyl-4-quinazolone. Parmar SS; Seth PK Can J Biochem; 1965 Jul; 43(7):1179-85. PubMed ID: 4285390 [No Abstract] [Full Text] [Related]
8. Correlation between selective inhibition of NAD-dependent oxidations and anticonvulsant property of quinazolone allylethers and quinazolone allyphenols. Parmar SS; Rastogi VK; Gupta TK; Arora RC Jpn J Pharmacol; 1970 Sep; 20(3):325-31. PubMed ID: 4321250 [No Abstract] [Full Text] [Related]
9. Anticonvulsant activity of nitrobenzamides and their inhibition of nicotinamide-adenine dinucleotide dependent oxidations. Parmar SS; Dwivedi C; Ali B; Misra RS J Med Chem; 1972 Aug; 15(8):846-8. PubMed ID: 4339772 [No Abstract] [Full Text] [Related]
10. Anticonvulsant activity and inhibition of respiration in rat brain homogenates by substituted oxadiazoles. Parmar SS; Joshi PC; Ali B; Cornatzer WE J Pharm Sci; 1974 Jun; 63(6):372-5. PubMed ID: 4368423 [No Abstract] [Full Text] [Related]
11. Substituted carbamides: interrelationship between anticonvulsant activity and inhibition of nicotinamide adenine dinucleotide-dependent pyruvic acid oxidation. Parmar SS; Dwivedi C; Ali B J Pharm Sci; 1972 Sep; 61(9):1366-9. PubMed ID: 4341622 [No Abstract] [Full Text] [Related]
12. Anticonvulsant activity of substituted indolealkylamines. Agarwal VK; Chaturvedi AK; Gupta TK; Parmar SS; De Boer B J Med Chem; 1974 Mar; 17(3):378-80. PubMed ID: 4811242 [No Abstract] [Full Text] [Related]
13. Selective inhibition of nicotinamide adenine dinucleotide dependent oxidations by substituted carbamides. Ali B; Parmar SS; Dwivedi C; Harbison RD Res Commun Chem Pathol Pharmacol; 1975 May; 11(1):163-6. PubMed ID: 168621 [TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant activity and selective inhibition of NAD-dependent oxidations by 1,4-disubstituted piperazines. Parmar SS; Chaudhary M; Chaudhary SK; Spiro HR Pharmacology; 1977; 15(2):112-7. PubMed ID: 191853 [TBL] [Abstract][Full Text] [Related]